"Arginine Vasopressin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The predominant form of mammalian antidiuretic hormone. It is a nonapeptide containing an ARGININE at residue 8 and two disulfide-linked cysteines at residues of 1 and 6. Arg-vasopressin is used to treat DIABETES INSIPIDUS or to improve vasomotor tone and BLOOD PRESSURE.
| Descriptor ID |
D001127
|
| MeSH Number(s) |
D06.472.699.631.692.781.100 D12.644.400.900.100 D12.644.456.925.100 D12.644.548.691.692.781.100 D12.776.631.650.937.100
|
| Concept/Terms |
Arginine Vasopressin- Arginine Vasopressin
- Argipressin
- Arg-Vasopressin
- Arg Vasopressin
- Vasopressin, Arginine
|
Below are MeSH descriptors whose meaning is more general than "Arginine Vasopressin".
Below are MeSH descriptors whose meaning is more specific than "Arginine Vasopressin".
This graph shows the total number of publications written about "Arginine Vasopressin" by people in this website by year, and whether "Arginine Vasopressin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 1 | 0 | 1 |
| 2007 | 0 | 1 | 1 |
| 2008 | 2 | 0 | 2 |
| 2012 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Arginine Vasopressin" by people in Profiles.
-
Sutton RM, Nadkarni VM, Berg RA. A "Pressin" paradigm shift for pediatric resuscitation science? Exception from informed consent can be done!. Pediatr Crit Care Med. 2012 May; 13(3):351-2.
-
Kumar SK, Mather PJ. AVP receptor antagonists in patients with CHF. Heart Fail Rev. 2009 Jun; 14(2):83-6.
-
Fuentes LQ, Reyes CE, Sarmiento JM, Villanueva CI, Figueroa CD, Navarro J, Gonz?lez CB. Vasopressin up-regulates the expression of growth-related immediate-early genes via two distinct EGF receptor transactivation pathways. Cell Signal. 2008 Sep; 20(9):1642-50.
-
Kumar S, Rubin S, Mather PJ, Whellan DJ. Hyponatremia and vasopressin antagonism in congestive heart failure. Clin Cardiol. 2007 Nov; 30(11):546-51.
-
Kraft W, Greenberg HE, Waldman SA. Paradoxical hypotension and bradycardia after intravenous arginine vasopressin. J Clin Pharmacol. 1998 Mar; 38(3):283-6.
-
Campling BG, Sarda IR, Baer KA, Pang SC, Baker HM, Lofters WS, Flynn TG. Secretion of atrial natriuretic peptide and vasopressin by small cell lung cancer. Cancer. 1995 May 15; 75(10):2442-51.
-
Wigle DA, Campling BG, Sarda IR, Shin SH, Watson JD, Frater Y, Flynn TG, Pang SC. ANP secretion from small cell lung cancer cell lines: a potential model of ANP release. Am J Physiol. 1995 May; 268(5 Pt 2):H1869-74.
-
Weaver JU, Kopelman PG, McLoughlin L, Forsling ML, Grossman A. Hyperactivity of the hypothalamo-pituitary-adrenal axis in obesity: a study of ACTH, AVP, beta-lipotrophin and cortisol responses to insulin-induced hypoglycaemia. Clin Endocrinol (Oxf). 1993 Sep; 39(3):345-50.
-
Marini JC, Nelson KK, Battey J, Siracusa LD. The pituitary hormones arginine vasopressin-neurophysin II and oxytocin-neurophysin I show close linkage with interleukin-1 on mouse chromosome 2. Genomics. 1993 Jan; 15(1):200-2.
-
Fuhr W, Russo K, Weiss HR. Effect of vasopressin on myocardial capillary recruitment and coronary blood flow in the anesthetized rabbit. Can J Physiol Pharmacol. 1991 Feb; 69(2):170-5.